COVID-19 pandemic
South Africa suspends its rollout of the Oxford-AstraZenenca vaccine after research finds that the vaccine is less effective against the 501.V2 variant discovered in the country.
Sources: Sky News
Changes
- South Africa suspends the rollout of Oxford-AstraZenenca's vaccine after the research finds it was less effective against a 501.V2 variant discovered in the country.
- South Africa suspends their rollout of the Oxford-AstraZenenca vaccine after research finds that the vaccine is less effective against the 501.V2 variant discovered in the country.
- South Africa suspends its rollout of the Oxford-AstraZenenca vaccine after research finds that the vaccine is less effective against the 501.V2 variant discovered in the country.